Gentel prepares to launch APiX platform, assays in H1 as it looks to build services arm
Gentel Biosciences, a nine-year-old privately held protein-array firm based in Madison, Wis., is planning to launch assays for carbohydrate and protein biomarker profiling this month, and to debut a new high-throughput microarray platform called APiX in June, according to a company official. Dan Clutter, Gentel's new...